WCMNY
NAMSW icon

Westchester Capital Management (New York)’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Westchester Capital Management (New York)’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,189
Closed -$97.6K – 252
2023
Q4 		$97.6K Hold
31,189
– – ﹤0.01% 216
2023
Q3 		$54.6K Hold
31,189
– – ﹤0.01% 246
2023
Q2 		$65.2K Hold
31,189
– – ﹤0.01% 261
2023
Q1 		$57.7K Hold
31,189
– – ﹤0.01% 303
2022
Q4 		$25K Buy
+31,189
New +$25.7K ﹤0.01% 390

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return

Westchester Capital Management (New York)'s NAMSW Position: Q1 2024 in Review

Westchester Capital Management (New York) sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2024, closing a stake of 31,189 shares — an estimated $97.6K sold.

Westchester Capital Management (New York) first reported a position in NAMSW in Q4 2022 and held it in 5 quarters. The position peaked at $97.6K in Q4 2023. 11 funds tracked by Wall St. Rank hold NAMSW as of Q1 2024.

  • Westchester Capital Management (New York) reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2024 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 31,189 NewAmsterdam Pharma Warrant shares in Q1 2024, an estimated $97.6K.
  • Westchester Capital Management (New York) first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 5 quarters.
  • Westchester Capital Management (New York)'s NewAmsterdam Pharma Warrant position peaked at $97.6K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2024.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2024, filed 15 May 2024.